Patents by Inventor Deborah Quinn

Deborah Quinn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230158260
    Abstract: Described are methods for improving oxygen saturation in patients suffering from hypoxemia, wherein said patients are receiving a continuous flow of oxygen at 10 L/min and exhibit an initial oxygen saturation of at least about 88%, comprising administering inhaled nitric oxide to said patients in an outpatient setting. Methods for improving quality of life for a hospitalized patient, reducing patient hospitalization time, and reducing costs associated with patient hospitalization are also described.
    Type: Application
    Filed: August 8, 2019
    Publication date: May 25, 2023
    Applicant: BELLEROPHON THERAPEUTICS
    Inventors: Parag SHAH, Deborah QUINN
  • Publication number: 20200384014
    Abstract: Described herein are methods of treating pulmonary hypertension by maintaining dosing frequency and/or minimizing skipped breaths during pulsed administration of inhaled nitric oxide.
    Type: Application
    Filed: December 28, 2018
    Publication date: December 10, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah QUINN, Parag SHAH, Martin DEKKER
  • Publication number: 20200360425
    Abstract: Described herein are methods of using inhaled nitric oxide for treating pulmonary hypertension, improving exercise capacity and/or reducing oxygen desaturation in a patient.
    Type: Application
    Filed: December 28, 2018
    Publication date: November 19, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah
  • Publication number: 20200360647
    Abstract: Described herein are methods of using inhaled nitric oxide for improving and/or maintaining right ventricular function and/or left ventricular function. Some methods relate to the long-term administration of inhaled nitric oxide to a patient with pulmonary hypertension.
    Type: Application
    Filed: August 29, 2018
    Publication date: November 19, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah
  • Publication number: 20200188319
    Abstract: Described herein are methods of using inhaled nitric oxide for treating pulmonary hypertension and/or improving oxygen saturation in a patient with a ventilation-perfusion (V/Q) mismatch and/or pulmonary hypertension associated with lung disease.
    Type: Application
    Filed: August 29, 2018
    Publication date: June 18, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah
  • Publication number: 20110190313
    Abstract: The present invention pertains to the use of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide or a pharmaceutically acceptable salt thereof or a pyrimidylaminobenzamide of formula I wherein the radicals and symbols are as defined herein, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for treating pulmonary arterial hypertension (PAH), especially in patients who failed prior PAH therapy.
    Type: Application
    Filed: August 11, 2009
    Publication date: August 4, 2011
    Inventors: Steve Pascoe, Deborah Quinn